These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 24344232)

  • 1. Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease.
    Sacchetti M; Mantelli F; Lambiase A; Mastropasqua A; Merlo D; Bonini S
    Br J Ophthalmol; 2014 Aug; 98(8):1016-22. PubMed ID: 24344232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratitis in Dry Eye Disease and Topical Ciclosporin A.
    Leonardi A; Flamion B; Baudouin C
    Ocul Immunol Inflamm; 2017 Aug; 25(4):577-586. PubMed ID: 28146363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis.
    Zhou XQ; Wei RL
    Cornea; 2014 Jul; 33(7):760-7. PubMed ID: 24815112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Human Tear Proteome Following Topical Treatment of Dry Eye Disease: Cyclosporine A Versus Diquafosol Tetrasodium.
    Ji YW; Kim HM; Ryu SY; Oh JW; Yeo A; Choi CY; Kim MJ; Song JS; Kim HS; Seo KY; Kim KP; Lee HK
    Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):5035-5044. PubMed ID: 31800960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical cyclosporine for atopic keratoconjunctivitis.
    González-López JJ; López-Alcalde J; Morcillo Laiz R; Fernández Buenaga R; Rebolleda Fernández G
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009078. PubMed ID: 22972132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Updated Systematic Review With Meta-Analysis Of Randomized Trials On Topical Cyclosporin A For Dry-Eye Disease.
    Tuan HI; Chi SC; Kang YN
    Drug Des Devel Ther; 2020; 14():265-274. PubMed ID: 32021110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.
    Sall K; Stevenson OD; Mundorf TK; Reis BL
    Ophthalmology; 2000 Apr; 107(4):631-9. PubMed ID: 10768324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Topical cyclosporine A and risk of ocular surface neoplasia].
    Rouimi F; Bouillot A; Baudouin C; Labbé A
    J Fr Ophtalmol; 2018 Feb; 41(2):122-128. PubMed ID: 29402465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Topical cyclosporine in ophthalmology: Pharmacology and clinical indications].
    Levy O; Labbé A; Borderie V; Laroche L; Bouheraoua N
    J Fr Ophtalmol; 2016 Mar; 39(3):292-307. PubMed ID: 26997607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies.
    Leonardi A; Messmer EM; Labetoulle M; Amrane M; Garrigue JS; Ismail D; Sainz-de-la-Maza M; Figueiredo FC; Baudouin C
    Br J Ophthalmol; 2019 Jan; 103(1):125-131. PubMed ID: 29545413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The place of ciclosporin A cationic emulsion 0.1% in the therapy of xerophthalmia].
    Maychuk DY; Yani EV; Brzheskiy VV; Grishina EE; Drozdova EA; Maychuk NV; Panova IE; Safonova TN
    Vestn Oftalmol; 2024; 140(2):102-111. PubMed ID: 38742506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease.
    Baudouin C; de la Maza MS; Amrane M; Garrigue JS; Ismail D; Figueiredo FC; Leonardi A
    Eur J Ophthalmol; 2017 Nov; 27(6):678-685. PubMed ID: 28708219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Eyes Topical Drug Delivery System: CsA-LNC for the Treatment of DED.
    Zhang A; Sun R; Ran M; Deng Y; Ge Y; Zhu Y; Tao X; Shang L; Gou J; He H; Yin T; Wang Y; Zhang Y; Tang X
    Pharm Res; 2020 Jul; 37(7):146. PubMed ID: 32666340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Clinical Efficacy and Safety of a Novel Cyclosporin A Nanoemulsion in the Treatment of Dry Eye Syndrome.
    Kim HS; Kim TI; Kim JH; Yoon KC; Hyon JY; Shin KU; Choi CY
    J Ocul Pharmacol Ther; 2017 Sep; 33(7):530-538. PubMed ID: 28759302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye.
    Daull P; Feraille L; Barabino S; Cimbolini N; Antonelli S; Mauro V; Garrigue JS
    Exp Eye Res; 2016 Dec; 153():159-164. PubMed ID: 27777121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the novel application of cyclosporine 0.1% in ocular surface disease.
    Boboridis KG; Konstas AGP
    Expert Opin Pharmacother; 2018 Jun; 19(9):1027-1039. PubMed ID: 29847195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study.
    Sheppard JD; Wirta DL; McLaurin E; Boehmer BE; Ciolino JB; Meides AS; Schlüter T; Ousler GW; Usner D; Krösser S
    Cornea; 2021 Oct; 40(10):1290-1297. PubMed ID: 34481407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebo-controlled phase III clinical study.
    Chen D; Zhang S; Bian A; Hong J; Deng Y; Zhang M; Chen W; Shao Y; Zhao J
    Medicine (Baltimore); 2019 Aug; 98(31):e16710. PubMed ID: 31374063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of dry eye disease.
    Lemp MA
    Am J Manag Care; 2008 Apr; 14(3 Suppl):S88-101. PubMed ID: 18452372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye.
    Guzey M; Karaman SK; Satici A; Ozardali I; Sezer S; Bozkurt O
    Clin Exp Ophthalmol; 2009 Aug; 37(6):541-9. PubMed ID: 19702702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.